Stevanato Group S.p.A. (STVN)

The company is best known for its role in high-value drug containment and delivery, where precision, sterility, and regulatory compliance are critical. Its products are used across biologics, vaccines, injectable drugs, and diagnostic applications, markets where packaging and delivery systems can be as important as the active therapy itself. Stevanato supports customers throughout the drug life cycle, from early development and clinical trials to large-scale manufacturing.

Stevanato reports through two main business areas. Biopharmaceutical and Diagnostic Solutions is the core revenue generator and covers containment products, delivery systems, diagnostic consumables, and associated services. The Engineering segment designs and builds equipment used in glass forming, inspection, assembly, and packaging, giving the group an integrated offering that combines manufacturing know-how with automated production technology.

Headquartered in Italy, Stevanato serves a global customer base and earns a significant share of revenue from Europe, the Middle East, and Africa. Its competitive position is supported by long-standing relationships with drug developers and manufacturers, technical expertise in glass and polymer systems, and exposure to structural healthcare trends such as injectable therapies, biologic medicines, self-administration, and growing demand for reliable diagnostic supply chains.